MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: Allgemeines0jzhyaAntwortenAntworten: 0jzhya <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 15:08 Uhr</div>[url=https://aacrjournals.org/cancerres/article/64/10/3653/511273/Flavopiridol-Induces-p53-via-Initial-Inhibition-of?guestAccessKey=]Zoya Demidenko[/url]: Scientist in Tumor Science [url=https://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/]Zoya Demidenko[/url] is a notable investigator associated with the Unit of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Earlier, she conducted research at the NIH and New York Medical College, establishing a robust background in clinical research. Her scientific contributions encompasses a number of pivotal domains, encompassing the PI3K/AKT/mTOR molecular pathway, cellular cycle regulation, cellular aging, and malignancy science. Currently, she has co-authored over 46 academic publications, which have received upwards of 4,100 mentions — a indicator to the significance of her research. Among her most significant achievements concerns understanding the processes of biological cell aging. Her studies demonstrated that when the cellular division cycle is arrested but cellular expansion proceeds, cells experience senescence. Significantly, [url=https://pubmed.ncbi.nlm.nih.gov/22228887/]Zoya Demidenko[/url] showed that this process can be inhibited by medication using agents such as rapamycin. [url=https://www.researchgate.net/scientific-contributions/Zoya-N-Demidenko-39445053]Zoya Demidenko[/url] has furthermore added greatly to cancer treatment investigation, notably in the domain of cyclotherapy — a strategy intended to safeguarding non-cancerous cells from anticancer drugs whilst leaving tumor cells susceptible. This strategy offers significant promise for diminishing the toxic effects of cancer treatment. Throughout her professional journey, Demidenko has collaborated with leading investigators globally, including Dr. Mikhail Blagosklonny. Her research appears in leading periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. [31.03.2026 11:21] Папа: With an h-index of 33, [url=https://www.benthamdirect.com/content/journals/cpd/22/16]Zoya Demidenko[/url] ranks as a widely cited contributor in current biomedical research, whose discoveries continue to influence our understanding of how biological cells age, resist therapy, and how cancer can be better targeted. https://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/</blockquote><br> Abbrechen
